Evidence map›Paper›PMID 28025390›Full record

ArticleCarcinogenesis2017

Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients.

Camille Ragin, Jeffrey C Liu, Gieira Jones, Olubunmi Shoyele, Bukola Sowunmi, Rachel Kennett, Harry J M Groen, Denise Gibbs, Elizabeth Blackman, Michael Esan and 26 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Head and Neck Cancer Survival Disparities by Race and Rural-Urban Context.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 11 countries.

Camille RaginCancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA Camille.ragin@fccc.edu.
Jeffrey C LiuDepartment of Otolaryngology, Temple University; and Fox Chase Cancer Center, Philadelphia, PA, USA.
Gieira JonesDepartment of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA.
Olubunmi ShoyeleDepartment of Pathology and Laboratory Medicine, Western Connecticut Health Network, Danbury Hospital, Danbury, CT, USA.
Bukola SowunmiCancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA.
Rachel KennettCancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA.
Harry J M GroenDepartment of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA.
Denise GibbsCancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA.
Elizabeth BlackmanCancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA.
Michael EsanCancer Prevention and Control Program, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA.
Margaret S BrandweinDepartment of Pathology and Anatomical Sciences, SUNY at the University at Buffalo, Buffalo, NY, USA.
Karthik DevarajanDepartment of Biostatistics, Fox Chase Cancer Center - Temple Health, Philadelphia, PA, USA.
Francesco BussuInstitute of Otolaryngology, Università Cattolica del Sacro Cuore, Policlinico Agostino Gemelli, Rome, Italy.
Rebecca ChernockDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Chih-Yen ChienDepartment of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Marc A CohenDepartment of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
El-Mofty SamirDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Suzuki MikioDepartment of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Gypsyamber D'SouzaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Pauline FunchainGenomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Charis EngGenomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
Susanne M GollinDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA USA.
Angela HongCentral Clinical School, The University of Sydney, Sydney, NSW, Australia.
Yuh-S JungDepartment of Otolaryngology, Research Institute and Hospital, National Cancer Center, Gyeonggi-do, Korea.
Maximilian KrügerDepartment of Oral and Maxillofacial Surgery - Plastic Surgery, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
James LewisDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN, 37232, USA.
Patrizia MorbiniDepartment of Molecular Medicine, Unit of Pathology, University of Pavia, and à IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
Santo LandolfoDepartment of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy.
Massimo RittàDepartment of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy.
Jos StraetmansDepartment of Otorhinolaryngology-Head and Neck Surgery, GROW Institute, Maastricht University Medical Centre, Maastricht, The Netherlands.
Krisztina SzarkaDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Hungary.
Ruth TachezyDepartment of Immunology, Institute of Hematology and Blood Transfusion National Reference Laboratory for Papillomaviruses, Prague, Czech Republic.
Francis P WordenDepartment of Internal Medicine, Division of Hematology-Oncology, University of Michigan, Ann Arbor, MI, USA.
Deborah NelsonDepartment of Epidemiology & Biostatistics, Temple University, College of Public Health, Philadelphia, PA, USA.
Samuel GathereNon Communicable Diseases Research Programme, Kenya Medical Research Institute, Nairobi, Kenya.
Emanuela TaioliDepartments of Population Health Science and Policy, of Thoracic Surgery, and Institute For Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Fox Chase Cancer Center · USTemple University · USCleveland Clinic Lerner College of Medicine · USTemple University Health System · USUniversity of Turin · ITWashington University in St. Louis · USIcahn School of Medicine at Mount Sinai · USInstitute of Haematology and Blood Transfusion · CZJohns Hopkins University · USKaohsiung Chang Gung Memorial Hospital · TWKenya Medical Research Institute · KEMaastricht University Medical Centre · NLMemorial Sloan Kettering Cancer Center · USNational Cancer Center · KRUniversità Cattolica del Sacro Cuore · ITUniversity at Buffalo, State University of New York · USUniversity Medical Center of the Johannes Gutenberg University Mainz · DEUniversity of Debrecen · HUUniversity of Michigan–Ann Arbor · USUniversity of Pavia · IT

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
Impacting the oral HPV continuum: prevention, screening, and early detectionR35DE026631 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI D'SOUZA, GYPSYAMBER · 2016 to 2023
$8.4M
NCI NIH HHS P30 CA006927NIDCR NIH HHS R35 DE026631
6 · The paper itself

Abstract

The landscape of HPV infection in racial/ethnic subgroups of head and neck cancer (HNC) patients has not been evaluated carefully. In this study, a meta-analysis examined the prevalence of HPV in HNC patients of African ancestry. Additionally, a pooled analysis of subject-level data was also performed to investigate HPV prevalence and patterns of p16 (CDNK2A) expression amongst different racial groups. Eighteen publications (N = 798 Black HNC patients) were examined in the meta-analysis, and the pooled analysis included 29 datasets comprised of 3,129 HNC patients of diverse racial/ethnic background. The meta-analysis revealed that the prevalence of HPV16 was higher among Blacks with oropharyngeal cancer than Blacks with non-oropharyngeal cancer. However, there was great heterogeneity observed among studies (Q test P<0.0001). In the pooled analysis, after adjusting for each study, year of diagnosis, age, gender and smoking status, the prevalence of HPV16/18 in oropharyngeal cancer patients was highest in Whites (61.1%), followed by 58.0% in Blacks and 25.2% in Asians (P<0.0001). There was no statistically significant difference in HPV16/18 prevalence in non-oropharyngeal cancer by race (P=0.682). With regard to the pattern of HPV16/18 status and p16 expression, White patients had the highest proportion of HPV16/18+/p16+ oropharyngeal cancer (52.3%), while Asians and Blacks had significantly lower proportions (23.0% and 22.6%, respectively) [P <0.0001]. Our findings suggest that the pattern of HPV16/18 status and p16 expression in oropharyngeal cancer appears to differ by race and this may contribute to survival disparities.

Identifiers

PMID28025390
PMCPMC7191086
OpenAlexW2562865704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.